<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>FDLI SmartBrief</title><description>Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.&amp;nbsp;Click&amp;nbsp; &lt;a href='http://www.smartbrief.com/fdli/index.jsp?sb_code=rss'&gt;here&lt;/a&gt; to subscribe.</description><link>http://www.smartbrief.com/news/fdli?sb_code=rss</link><image><url>http://www.smartbrief.com/images/homepage/hed-smartbrief.gif</url><title>FDLI SmartBrief</title><link>http://www.smartbrief.com/news/fdli?sb_code=rss</link></image><language>en-us</language><lastBuildDate>19 Jun 2013 08:40:11 CDT</lastBuildDate><item><title>Glenmark's sclerosis drug Riluzole gets FDA OK</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DDF0A6368-57AB-4371-BF38-F72AB86F4125%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DDF0A6368-57AB-4371-BF38-F72AB86F4125%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The FDA approved Glenmark Generics' Riluzole to treat amyotrophic lateral sclerosis, a nervous-system disorder. &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DDF0A6368-57AB-4371-BF38-F72AB86F4125%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Drugs &amp; Biologics</category></item><item><title>2 deaths of patients on Lilly schizophrenia drug investigated by FDA</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D3DAE569A-AF52-4684-A46B-86085EEA9165%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D3DAE569A-AF52-4684-A46B-86085EEA9165%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The FDA is investigating two unexplained deaths of patients who were taking Eli Lilly and Co.'s long-acting schizophrenia inj&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D3DAE569A-AF52-4684-A46B-86085EEA9165%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Drugs &amp; Biologics</category></item><item><title>Supreme Court ruling on patent settlements secures competition</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D02EF8F37-6367-475A-897B-37A2D1892A59%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D02EF8F37-6367-475A-897B-37A2D1892A59%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The Supreme Court's verdict allowing the Federal Trade Commission to legally challenge patent settlements provides the agency&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D02EF8F37-6367-475A-897B-37A2D1892A59%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Drugs &amp; Biologics</category></item><item><title>FDA drug compliance chief shares agency's goals, challenges</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFDA2E7BC-896D-4AC4-B53C-623EEFC83761%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFDA2E7BC-896D-4AC4-B53C-623EEFC83761%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Safeguarding the public from ineffective and unsafe medicines is a major job that entails numerous challenges, writes Howard &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFDA2E7BC-896D-4AC4-B53C-623EEFC83761%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Drugs &amp; Biologics</category></item><item><title>Lawmakers seek more U.S. pressure on India to reform trade policies</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DCB098A67-D05C-4BB3-964E-6D224EB637CC%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DCB098A67-D05C-4BB3-964E-6D224EB637CC%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">More than 170 U.S. &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DCB098A67-D05C-4BB3-964E-6D224EB637CC%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Global Focus</category></item><item><title>Bill to boost FDA funding by $53M clears Senate panel</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFBBF1F5A-42DC-49A7-B7E2-EC5F98BDC35E%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFBBF1F5A-42DC-49A7-B7E2-EC5F98BDC35E%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">A bill that would add $53 million to the FDA's funding for the Food Safety Modernization Act's implementation was approved by&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DFBBF1F5A-42DC-49A7-B7E2-EC5F98BDC35E%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Food &amp; Dietary Supplements</category></item><item><title>FDA drops plan to regulate fecal transplant procedures</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D7ABFE29F-6ADE-4F5B-8346-CD496C6F061F%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D7ABFE29F-6ADE-4F5B-8346-CD496C6F061F%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The FDA will no longer require regulatory approval for doctors to perform fecal transplants, provided the procedure be used o&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D7ABFE29F-6ADE-4F5B-8346-CD496C6F061F%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Medical Devices</category></item><item><title>Mendor wins EU approval for diabetes management app</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DE371DF4C-C2B1-42A5-9739-9871A788C970%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DE371DF4C-C2B1-42A5-9739-9871A788C970%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Mendor has earned the CE mark in Europe for Mendor Balance, an online diabetes management application that works with the com&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DE371DF4C-C2B1-42A5-9739-9871A788C970%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Medical Devices</category></item><item><title>Sorin prepares to launch advanced pacemakers in Europe</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D961534B4-6D60-44EF-BB0D-C4E230BF984C%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D961534B4-6D60-44EF-BB0D-C4E230BF984C%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">Sorin is introducing its REPLY 200 SR and DR cardiac pacemakers in Europe, which comes on the heels of a CE mark approval for&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D961534B4-6D60-44EF-BB0D-C4E230BF984C%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Medical Devices</category></item><item><title>FDA to use data mining to uncover illegal cigarette sales</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D5CC92DC2-D41B-4A4F-820B-12FE29106F3F%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D5CC92DC2-D41B-4A4F-820B-12FE29106F3F%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">The FDA plans to analyze commercial shipping data from the past six years in order to uncover illegal cigarette sales or sale&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D5CC92DC2-D41B-4A4F-820B-12FE29106F3F%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>Tobacco</category></item><item><title>2013 conference calendar -- speak, register and save the dates!</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D499308AF-67E5-4D7C-AE30-625488C85444%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D499308AF-67E5-4D7C-AE30-625488C85444%26brief%3Dfdli%26sb_code%3Drss%26%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">There are plenty of speaking opportunities available for this year's FDLI conferences. &nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3D499308AF-67E5-4D7C-AE30-625488C85444%26brief%3DFDLI%26sb_code%3Drss%26%26campaign%3Drss">More</a>-&nbsp;</div><p><div style="background-image:url('/images/briefs/common/graphicbox_top.gif');background-repeat:no-repeat;clear:both;margin:0 auto;margin-top:14px;border:1px solid #000000;padding:4px;padding-top:18px;"><strong>SR COUNSEL - 13000001ME</strong>
<br/>Abbvie</div></p>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>FDLI Items</category></item><item><title>Vanity is the quicksand of reason.</title><guid>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DD8948286-3B31-4422-898C-3386C513C7BD%26brief%3Dfdli%26sb_code%3Drss%26campaign%3Drss</guid><link>http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DD8948286-3B31-4422-898C-3386C513C7BD%26brief%3Dfdli%26sb_code%3Drss%26campaign%3Drss</link><description><![CDATA[<div style="clear:both;margin:20px auto;color:#666;">George Sand, French novelist and memoirist&nbsp;-<a href="http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FquoteDetails.jsp%3Fissueid%3D4565F332-63AF-481E-A185-0B63EA36B41C%26copyid%3DD8948286-3B31-4422-898C-3386C513C7BD%26brief%3DFDLI%26sb_code%3Drss%26campaign%3Drss">More</a>-&nbsp;</div>]]></description><pubDate>19 Jun 2013 08:40:11 CDT</pubDate><category>SmartQuote</category></item></channel></rss>